Arda Durmaz

827 total citations
50 papers, 305 citations indexed

About

Arda Durmaz is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Arda Durmaz has authored 50 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 19 papers in Molecular Biology and 18 papers in Genetics. Recurrent topics in Arda Durmaz's work include Acute Myeloid Leukemia Research (30 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers) and Cancer Genomics and Diagnostics (12 papers). Arda Durmaz is often cited by papers focused on Acute Myeloid Leukemia Research (30 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers) and Cancer Genomics and Diagnostics (12 papers). Arda Durmaz collaborates with scholars based in United States, Italy and Spain. Arda Durmaz's co-authors include Jacob G. Scott, Valeria Visconte, Carmelo Gurnari, Andriy Marusyk, Andrew Dhawan, Jaroslaw P. Maciejewski, Masahiro Hitomi, Mohamed E. Abazeed, Waled Bahaj and Nara Yoon and has published in prestigious journals such as Nature Communications, Blood and Scientific Reports.

In The Last Decade

Arda Durmaz

43 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arda Durmaz United States 10 145 94 71 66 55 50 305
Samantha Bruno Italy 13 228 1.6× 85 0.9× 69 1.0× 67 1.0× 59 1.1× 40 417
Paloma Silva de Souza Brazil 12 194 1.3× 104 1.1× 63 0.9× 114 1.7× 69 1.3× 15 333
María Piedad Fernández-Pérez Spain 12 202 1.4× 55 0.6× 79 1.1× 72 1.1× 16 0.3× 15 368
Margot Revel France 8 122 0.8× 58 0.6× 39 0.5× 77 1.2× 21 0.4× 15 423
Victoria Ling Australia 6 143 1.0× 28 0.3× 35 0.5× 140 2.1× 18 0.3× 12 270
Deepak Bararia Germany 11 206 1.4× 146 1.6× 37 0.5× 78 1.2× 53 1.0× 17 446
Sylvanie Surget France 7 295 2.0× 77 0.8× 71 1.0× 164 2.5× 17 0.3× 7 433
Nicolas Frances Switzerland 11 221 1.5× 21 0.2× 71 1.0× 191 2.9× 78 1.4× 22 436
Yin Gu United States 13 211 1.5× 35 0.4× 95 1.3× 137 2.1× 22 0.4× 23 491
Musalula Sinkala Zambia 10 188 1.3× 13 0.1× 122 1.7× 107 1.6× 20 0.4× 29 380

Countries citing papers authored by Arda Durmaz

Since Specialization
Citations

This map shows the geographic impact of Arda Durmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arda Durmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arda Durmaz more than expected).

Fields of papers citing papers by Arda Durmaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arda Durmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arda Durmaz. The network helps show where Arda Durmaz may publish in the future.

Co-authorship network of co-authors of Arda Durmaz

This figure shows the co-authorship network connecting the top 25 collaborators of Arda Durmaz. A scholar is included among the top collaborators of Arda Durmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arda Durmaz. Arda Durmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gurnari, Carmelo, Carlos Bravo‐Pérez, Arda Durmaz, et al.. (2025). Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia. Leukemia. 39(3). 748–751. 3 indexed citations
2.
3.
Vargas, Roberto, Aaron Petty, Daniel J. Lindner, et al.. (2025). Synergistic effect of MDM2 inhibitors and radiotherapy in endometrial cancer. npj Precision Oncology. 9(1). 290–290.
4.
Bravo‐Pérez, Carlos, Zoe Brady, Arda Durmaz, et al.. (2024). Budd-Chiari Syndrome: Pathogenetic Factors and Completeness of Screening for Paroxysmal Nocturnal Hemoglobinuria. Blood. 144(Supplement 1). 1254–1254.
5.
Kubota, Yasuo, Carlos Bravo‐Pérez, Carmelo Gurnari, et al.. (2024). Genomic Landscape of Germline RUNX1 variants in Adult Myeloid Neoplasia According to Functional Impact. Blood. 144(Supplement 1). 1328–1328. 1 indexed citations
6.
7.
Awada, Hussein, Carmelo Gurnari, Valeria Visconte, et al.. (2024). Clonal hematopoiesis–derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders. Leukemia. 38(6). 1266–1274. 5 indexed citations
8.
Kewan, Tariq, Arda Durmaz, Waled Bahaj, et al.. (2024). Clinical and Molecular Insights into the Classification Dilemma: Are MDS/AML Cases Distinct from Secondary AML?. Blood. 144(Supplement 1). 850–850. 1 indexed citations
9.
Kawashima, Naomi, Carmelo Gurnari, Carlos Bravo‐Pérez, et al.. (2024). Clonal hematopoiesis in large granular lymphocytic leukemia. Leukemia. 39(2). 451–459. 2 indexed citations
10.
Awada, Hussein, Arda Durmaz, Tariq Kewan, et al.. (2024). Context-dependent role of trisomy 6 in myelodysplastic neoplasms and acute myeloid leukemia: a multi-omics analysis. Leukemia. 38(6). 1411–1414.
11.
12.
Piciocchi, Alfonso, Tiziana Ottone, Emiliano Fabiani, et al.. (2023). Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting. Blood Advances. 7(17). 5122–5131. 11 indexed citations
13.
Kewan, Tariq, Waled Bahaj, Arda Durmaz, et al.. (2023). Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes. Blood. 141(14). 1768–1772. 18 indexed citations
14.
Mori, Minako, Yasuo Kubota, Arda Durmaz, et al.. (2023). Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets. Leukemia. 37(10). 2082–2093. 10 indexed citations
15.
Bahaj, Waled, Tariq Kewan, Danai Dima, et al.. (2023). Splenectomy outcomes in immune cytopenias: Treatment outcomes and determinants of response. Journal of Internal Medicine. 295(2). 229–241. 2 indexed citations
16.
Durmaz, Arda, Carlos Bravo‐Pérez, Yasuo Kubota, et al.. (2023). Association Vs Causation: Epidemiologic Clues As to the Autoimmune Pathogenesis of MDS. Blood. 142(Supplement 1). 4066–4066. 1 indexed citations
17.
Bahaj, Waled, Tariq Kewan, Carmelo Gurnari, et al.. (2023). Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia. Journal of Hematology & Oncology. 16(1). 91–91. 14 indexed citations
18.
Awada, Hussein, Carmelo Gurnari, Arda Durmaz, et al.. (2022). Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes. International Journal of Molecular Sciences. 23(5). 2802–2802. 10 indexed citations
19.
Durmaz, Arda & Jacob G. Scott. (2022). Stability of scRNA-Seq Analysis Workflows is Susceptible to Preprocessing and is Mitigated by Regularized or Supervised Approaches. Evolutionary Bioinformatics. 18. 3253684202–3253684202. 2 indexed citations
20.
Scarborough, Jessica, Peter M. Anderson, Andrew Dhawan, et al.. (2020). Identifying States of Collateral Sensitivity during the Evolution of Therapeutic Resistance in Ewing's Sarcoma. iScience. 23(7). 101293–101293. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samantha Bruno Breakdown of academic impact, for papers by Paloma Silva de Souza Breakdown of academic impact, for papers by María Piedad Fernández-Pérez Breakdown of academic impact, for papers by Margot Revel Breakdown of academic impact, for papers by Victoria Ling Breakdown of academic impact, for papers by Deepak Bararia Breakdown of academic impact, for papers by Sylvanie Surget Breakdown of academic impact, for papers by Nicolas Frances Breakdown of academic impact, for papers by Yin Gu Breakdown of academic impact, for papers by Musalula Sinkala
Rankless by CCL
2026